Literature DB >> 11356828

X-linked inhibitor of apoptosis protein functions as a cofactor in transforming growth factor-beta signaling.

S Birkey Reffey1, J U Wurthner, W T Parks, A B Roberts, C S Duckett.   

Abstract

X-linked inhibitor of apoptosis protein (XIAP) is a potent suppressor of apoptotic cell death, which functions by directly inhibiting caspases, the principal effectors of apoptosis. Here we report that XIAP can also function as a cofactor in the regulation of gene expression by transforming growth factor-beta (TGF-beta). XIAP, but not the related proteins c-IAP1 or c-IAP2, associated with several members of the type I class of the TGF-beta receptor superfamily and potentiated TGF-beta-induced signaling. Although XIAP-mediated activation of c-Jun N-terminal kinase and nuclear factor kappa B was found to require the TGF-beta signaling intermediate Smad4, the ability of XIAP to suppress apoptosis was found to be Smad4-independent. These data implicate a role for XIAP in TGF-beta-mediated signaling that is distinct from its anti-apoptotic functions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11356828     DOI: 10.1074/jbc.M100331200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  A novel role for XIAP in copper homeostasis through regulation of MURR1.

Authors:  Ezra Burstein; Lakshmanan Ganesh; Robert D Dick; Bart van De Sluis; John C Wilkinson; Leo W J Klomp; Cisca Wijmenga; George J Brewer; Gary J Nabel; Colin S Duckett
Journal:  EMBO J       Date:  2003-12-18       Impact factor: 11.598

Review 2.  Reawakening the cellular death program in neoplasia through the therapeutic blockade of IAP function.

Authors:  Casey W Wright; Colin S Duckett
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

Review 3.  Apoptosis in liver carcinogenesis and chemotherapy.

Authors:  Joaquim Moreno-Càceres; Isabel Fabregat
Journal:  Hepat Oncol       Date:  2015-11-11

Review 4.  Small-molecule SMAC mimetics as new cancer therapeutics.

Authors:  Longchuan Bai; David C Smith; Shaomeng Wang
Journal:  Pharmacol Ther       Date:  2014-05-16       Impact factor: 12.310

5.  XIAP reduces muscle proteolysis induced by CKD.

Authors:  Junping Hu; Jie Du; Liping Zhang; S Russ Price; Janet D Klein; Xiaonan H Wang
Journal:  J Am Soc Nephrol       Date:  2010-04-29       Impact factor: 10.121

6.  XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease.

Authors:  Rebecca A Marsh; Lisa Madden; Brenda J Kitchen; Rajen Mody; Brad McClimon; Michael B Jordan; Jack J Bleesing; Kejian Zhang; Alexandra H Filipovich
Journal:  Blood       Date:  2010-05-20       Impact factor: 22.113

7.  AIF promotes a JNK1-mediated cadherin switch independently of respiratory chain stabilization.

Authors:  Andrew J Scott; Sierra A Walker; Joshua J Krank; Amanda S Wilkinson; Kaitlyn M Johnson; Eric M Lewis; John C Wilkinson
Journal:  J Biol Chem       Date:  2018-08-09       Impact factor: 5.157

8.  TAK1-TAB2 signaling contributes to bone destruction by breast carcinoma cells.

Authors:  Alfiya Safina; Paula Sotomayor; Michelle Limoge; Carl Morrison; Andrei V Bakin
Journal:  Mol Cancer Res       Date:  2011-06-23       Impact factor: 5.852

9.  BMP4 supports self-renewal of embryonic stem cells by inhibiting mitogen-activated protein kinase pathways.

Authors:  Xiaoxia Qi; Teng-Guo Li; Jing Hao; Jie Hu; Jing Wang; Holly Simmons; Shigeto Miura; Yuji Mishina; Guang-Quan Zhao
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-09       Impact factor: 11.205

10.  Transforming growth factor beta isoforms regulation of Akt activity and XIAP levels in rat endometrium during estrous cycle, in a model of pseudopregnancy and in cultured decidual cells.

Authors:  Pierre-Luc Caron; Guylaine Fréchette-Frigon; Carl Shooner; Valérie Leblanc; Eric Asselin
Journal:  Reprod Biol Endocrinol       Date:  2009-08-05       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.